EBS R&D Expense Growth
Emergent Biosolutions Inc · R&D Expense Growth
EBS R&D Expense Growth
Latest reported-23.90%period ending
EBS FY R&D Growth (YoY) (0.00% → -23.90%)
Latest values, visible window
High-resolution chart · PNG
EBS r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -23.9038% | |
| -36.535% | |
| -40.8391% | |
| -19.9405% | |
| -1.1349% | |
| 5.1724% | |
| 58.4034% | |
| 46.6119% | |
| -8.8868% | |
| -10.3083% | |
| 13.8129% | |
| -12.6837% | |
| -7.6202% | |
| 4.0006% | |
| 39.7973% | |
| 19.7176% | |
| 25.4212% | |
| 10.2154% | |
| 18.5864% | |
| 147.5437% | |
| 81.6843% | |
| 0% | |
| -100% | |
| -98.5451% | |
| 0% |